Ignite Creation Date:
2024-10-26 @ 3:40 PM
Last Modification Date:
2024-10-26 @ 3:40 PM
Study NCT ID:
NCT06593704
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-08-29
Brief Title:
Proactive Population Health Management of Cardiovascular Disease in Primary Care Using the PROSPERA-program
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Proactive Population Health Management of Cardiovascular Disease in Primary Care Using a Multilevel Guideline Adherence Toolkit the PROSPERA-program
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
PROSPERA
Brief Summary:
The PROSPERA-program is a complex multilevel approach that includes training for healthcare providers a risk assessment process and decision support tools to help match patients with the appropriate treatment based on their care needs
The goal of this clinical trial is to determine if the PROSPERA-program can improve the cardiovascular risk profile in patients aged 40-90 years enrolled in primary care programs for increased cardiovascular risk such as cardiovascular disease increased vascular risk or diabetes
The main question it aims to answer is
Does the cardiovascular risk profile improve for patients using the PROSPERA-program
Researchers will compare the PROSPERA-program with standard cardiovascular care to see if the program enhances cardiovascular population health in primary care
Additionally the study will assess how well the PROSPERA-program fits into the workflow of primary care providers and supports shared decision-making
Participants will
Receive a consultation with their general practitioner or practice nurse according to the PROSPERA-program
Have their routinely collected healthcare data used for evaluation
Be asked to complete a questionnaire or participate in an interview for a subset of patients
The goal of this clinical trial is to determine if the PROSPERA-program can improve the cardiovascular risk profile in patients aged 40-90 years enrolled in primary care programs for increased cardiovascular risk such as cardiovascular disease increased vascular risk or diabetes
The main question it aims to answer is
Does the cardiovascular risk profile improve for patients using the PROSPERA-program
Researchers will compare the PROSPERA-program with standard cardiovascular care to see if the program enhances cardiovascular population health in primary care
Additionally the study will assess how well the PROSPERA-program fits into the workflow of primary care providers and supports shared decision-making
Participants will
Receive a consultation with their general practitioner or practice nurse according to the PROSPERA-program
Have their routinely collected healthcare data used for evaluation
Be asked to complete a questionnaire or participate in an interview for a subset of patients
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None